Viewing Study NCT03391934


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-26 @ 1:08 AM
Study NCT ID: NCT03391934
Status: RECRUITING
Last Update Posted: 2023-04-05
First Post: 2017-12-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer
Sponsor: Cinnagen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module